From: On myocardial siderosis and left ventricular dysfunction in hemochromatosis
Number of patients | Â | 10 |
Male/Female | Â | 6/4 |
Age (years): mean [SD] | Â | 60.0 [15.9] |
Weight (kg): mean [SD] | Â | 70.4 [16.4] |
Height (cm): mean [SD] | Â | 175 [10.6] |
Race | Caucasian | 10 |
Genetic mutation analysis: N (%) | C282Y/wt | 5 (50%) |
 | H63D/H63D | 4 (40%) |
 | H63D/wt | 1 (10%) |
Presentation ferritin (μg/L): median [Q1, Q3]; Normal 30-400 |  | 920 [660, 1912] |
Iron (μmol/L): mean [SD]; Normal 9-30 |  | 34.0 [11.6] |
Iron binding saturation (%): mean [SD]; Normal 25-50 | Â | 64.8 [18.7] |
Hb (g/dL): mean [SD]; Normal 13-15 | Â | 13.6 [1.4] |
Liver T2* (ms): median [Q1, Q3]; Normal 26.7 ±4.2 ms |  | 16.4 [6.3, 23.0] |
Liver iron concentration (mg/g dw): median [Q1, Q3] | Â | 1.8 [1.3, 4.2] |
LV EDV/BSA (mL/m2): median [Q1, Q3]; Normal 60-95 | Â | 79 [64, 83] |
LV ESV/BSA (mL/m2): median [Q1, Q3]; Normal 16-36 | Â | 22 [19, 38] |
LV EF (%): median [Q1, Q3]; Normal 58-76 | Â | 68 [63, 72] |
LV mass/BSA (g/m2): median [Q1, Q3]; Normal 53-84 | Â | 80 [74, 89] |
Cardiac T2* (ms): median [Q1, Q3]; Normal 40 ms | Â | 30.9 [26.8, 34.5] |
Cardiac iron concentration (mg/g dw): median [Q1, Q3] | Â | 0.68 [0.60, 0.81] |